Spectris (LON:SXS) was downgraded by stock analysts at Morgan Stanley to an “underweight” rating in a report issued on Thursday, Digital Look reports. They presently have a GBX 3,150 ($41.15) target price on the stock, down from their prior target price of GBX 3,370 ($44.03). Morgan Stanley’s price target indicates a potential downside of 12.18% from the company’s previous close.
Other research analysts have also recently issued reports about the company. Liberum Capital reissued a “hold” rating and set a GBX 3,000 ($39.20) price target on shares of Spectris in a research report on Friday, November 5th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 438 ($5.72) price objective on shares of Spectris in a research report on Monday. Barclays raised their price objective on Spectris from GBX 3,920 ($51.22) to GBX 4,370 ($57.09) and gave the company an “overweight” rating in a research report on Friday, October 15th. JPMorgan Chase & Co. raised their price objective on Spectris from GBX 2,900 ($37.89) to GBX 3,200 ($41.81) and gave the company a “neutral” rating in a research report on Friday, July 30th. Finally, Shore Capital reaffirmed a “sell” rating on shares of Spectris in a research report on Thursday, October 21st. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of GBX 2,831.60 ($37.00).
LON SXS traded down GBX 84 ($1.10) during trading hours on Thursday, hitting GBX 3,587 ($46.86). 136,493 shares of the company traded hands, compared to its average volume of 273,450. The business’s 50-day moving average is GBX 3,802.26 and its 200-day moving average is GBX 5,808.73. Spectris has a twelve month low of GBX 2,613 ($34.14) and a twelve month high of GBX 4,167 ($54.44). The company has a debt-to-equity ratio of 3.11, a quick ratio of 1.61 and a current ratio of 2.13. The stock has a market capitalization of £3.97 billion and a price-to-earnings ratio of 18.13.
Spectris plc manufactures and sells measuring instruments and controls worldwide. The company provides products and services, which enable customers to determine structure, composition, quantity, and quality of particles and materials during their research and product development processes, when assessing materials before production, or during the manufacturing process; various range of life science services; products for measurement and control of temperature, humidity, pressure, strain, force, flow, level, pH, and conductivity; and data acquisition, electric heating, and custom-engineered products.
Featured Story: What is a portfolio manager?
Receive News & Ratings for Spectris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectris and related companies with MarketBeat.com's FREE daily email newsletter.